Live Breaking News & Updates on Jamesm frates

Stay updated with breaking news from Jamesm frates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amylyx Pharmaceuticals (NASDAQ:AMLX) Releases Quarterly Earnings Results, Misses Estimates By $0.70 EPS

Amylyx Pharmaceuticals (NASDAQ:AMLX) Releases Quarterly Earnings Results, Misses Estimates By $0.70 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Leerink-partnrs , Jamesm-frates , Robertw-baird , Joshuab-cohen , Goldman-sachs-group , Earnings-history-for-amylyx-pharmaceuticals , Amylyx-pharmaceuticals-trading-down , Amylyx-pharmaceuticals-inc , News-ratings-for-amylyx-pharmaceuticals-daily , Amylyx-pharmaceuticals

Amylyx Pharmaceuticals (AMLX) Set to Announce Quarterly Earnings on Thursday

Amylyx Pharmaceuticals (AMLX) Set to Announce Quarterly Earnings on Thursday
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Joshuab-cohen , Jamesm-frates , Leerink-partnrs , Amylyx-pharmaceuticals , Amylyx-pharmaceuticals-inc , News-ratings-for-amylyx-pharmaceuticals-daily , Earnings-history-for-amylyx-pharmaceuticals , Goldman-sachs-group , Amylyx-pharmaceuticals-stock-performance , Nasdaq

Amylyx Pharmaceuticals (NASDAQ:AMLX) Downgraded by Robert W. Baird

Amylyx Pharmaceuticals (NASDAQ:AMLX) Downgraded by Robert W. Baird
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , China , United-states , Robertw-baird , Patrickd-yeramian , Jamesm-frates , Royal-bank , Goldman-sachs-group , Amylyx-pharmaceuticals , Deutsche-bank-aktiengesellschaft , Institutional-investors-weigh-in-on-amylyx-pharmaceuticals

Amylyx Pharmaceuticals' (AMLX) In-Line Rating Reiterated at Evercore ISI

Amylyx Pharmaceuticals' (AMLX) In-Line Rating Reiterated at Evercore ISI
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Jamesm-frates , Gina-mazzariello , Robertw-baird , Primecap-management-co , Insider-transactions-at-amylyx-pharmaceuticals , Securities-exchange-commission , Rafferty-asset-management , Qube-research-technologies-ltd , News-ratings-for-amylyx-pharmaceuticals-daily , Analyst-recommendations-for-amylyx-pharmaceuticals

Amylyx Pharmaceuticals (NASDAQ:AMLX) Earns Neutral Rating from The Goldman Sachs Group

The Goldman Sachs Group restated their neutral rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. Several other brokerages have also recently issued reports on AMLX. Robert W. Baird assumed coverage on shares of Amylyx Pharmaceuticals in a report on Wednesday, January 3rd. They […]

Canada , United-states , Jamesm-frates , Patrickd-yeramian , Robertw-baird , Rafferty-asset-management , Analyst-recommendations-for-amylyx-pharmaceuticals , News-ratings-for-amylyx-pharmaceuticals-daily , Amylyx-pharmaceuticals-stock-performance , Qube-research-technologies-ltd , Primecap-management-co

Evercore ISI Reiterates In-Line Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX)

Evercore ISI Reiterates In-Line Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Jamesm-frates , Justinb-klee , Robertw-baird , Institutional-trading-of-amylyx-pharmaceuticals , Amylyx-pharmaceuticals-company-profile , Goldman-sachs-group , Amylyx-pharmaceuticals-inc , Amylyx-pharmaceuticals-price-performance , Wells-fargo-company

Amylyx Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:AMLX)

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) saw unusually large options trading activity on Friday. Stock investors purchased 9,214 call options on the stock. This is an increase of approximately 224% compared to the average daily volume of 2,843 call options. Wall Street Analysts Forecast Growth Several brokerages recently commented on AMLX. The Goldman […]

Canada , Hong-kong , United-states , Mizuho , Sakhalinskaya-oblast- , Russia , China , Gina-mazzariello , Robertw-baird , Jamesm-frates , China-universal-asset-management-co , Amylyx-pharmaceuticals

James M. Frates Sells 1,792 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock

James M. Frates Sells 1,792 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Blackrock , Nova-scotia , Jamesm-frates , Robertw-baird , Amylyx-pharmaceuticals , Goldman-sachs-group , Amylyx-pharmaceuticals-price-performance , Blackrock-inc , Amylyx-pharmaceuticals-inc

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) CFO Sells $33,564.16 in Stock

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) CFO James M. Frates sold 1,792 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $18.73, for a total transaction of $33,564.16. Following the completion of the transaction, the chief financial officer now owns 134,784 […]

United-states , Canada , Blackrock , Nova-scotia , Jamesm-frates , Robertw-baird , Marshall-wace , Blackrock-inc , Amylyx-pharmaceuticals-inc , Amylyx-pharmaceuticals-company-profile , Deutsche-bank-aktiengesellschaft

Connor Clark & Lunn Investment Management Ltd. Invests $2.28 Million in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)

Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 124,455 shares of the company’s stock, valued at approximately $2,279,000. Connor Clark […]

Canada , United-states , China , Patrickd-yeramian , Robertw-baird , Jamesm-frates , Tower-research-capital , Goldman-sachs-group , Connor-clark-lunn-investment-management-ltd , Quarter-for-amylyx-pharmaceuticals , Amylyx-pharmaceuticals-inc